查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球牙科軟組織再生市場：按產品類型、按應用、按最終用戶、按地區 - 預測至 2029 年
市場調查報告書
商品編碼
1608634

全球牙科軟組織再生市場：按產品類型、按應用、按最終用戶、按地區 - 預測至 2029 年

Dental Soft-Tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 226 Pages | 訂單完成後即時交付

價格

牙科軟組織再生市場規模預計將從 2024 年的 3.7 億美元增加到 2029 年的 5.4 億美元，預測期內複合年成長率為 7.8%。由於多種因素，包括牙周病患病率的上升、口腔健康意識的增強以及美容牙科的成長趨勢，牙科軟組織再生市場正在經歷強勁成長。此外，低度開發地區的醫療基礎設施發展措施需要更多的牙科護理和相關產品。此外，再生生物材料的進步也在市場成長中發揮重要作用。

調查範圍
調查年份 2024-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（百萬美元/十億美元）
按細分市場 按產品類型、按應用、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

從產品類型來看，由於多種因素，基於膠原蛋白的薄膜預計將主導牙科軟組織再生市場。膠原蛋白膜支持牙周和植入缺陷的癒合，並作為引導組織生長的屏障。此外，這些膜能夠與周圍組織整合並支持新結締組織的生長。此外，再生生物材料的技術創新進一步推動了該市場的成長。

從應用來看，由於人口老化的加劇、口腔健康意識的提高以及美容牙科需求的增加，植入領域預計將在牙科軟組織再生市場中佔據最大的市場佔有率。此外，膠原蛋白膜、軟組織移植物和高生物活性材料等產品擴大用於促進植入癒合。此外，軟組織再生解決方案的技術創新和牙科美學意識的提高進一步推動了牙科軟組織再生市場的成長。

該報告研究了全球牙科軟組織再生市場，包括按產品類型、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 產業動態
  • 價值鏈分析
  • 技術分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 監理情勢分析
  • 專利分析
  • 貿易分析
  • 價格分析
  • 2024-2025年重大會議和活動
  • 未滿足的需求/最終用戶的期望
  • 鄰近市場分析
  • 生態系分析
  • 案例研究分析
  • 供應鏈分析
  • 影響客戶業務的趨勢/干擾
  • 投資金籌措場景
  • 贖回場景分析
  • 人工智慧/產生人工智慧對牙科軟組織再生市場的影響
  • 2023 年主要地區牙齦疾病盛行率
  • 2023年主要地區手術總數

第6章牙科軟組織再生市場（依產品類型）

  • 介紹
    • 膠原膠原蛋白膜
    • 自體移植
    • 生醫材料
    • 其他

第7章牙科軟組織再生市場（依應用）

  • 介紹
    • 植入
    • 牙周病學
    • 其他

第8章牙科軟組織再生市場（按最終用戶）

  • 介紹
  • 牙醫診所
  • DSO/獨立診所
  • 學術研究所

第9章牙科軟組織再生市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟前景
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東/非洲
    • 政府為支持市場成長所採取的基礎建設發展舉措
    • 中東和非洲的宏觀經濟前景
  • 海灣合作理事會國家
    • 可支配所得的增加推動市場成長
    • 海灣合作理事會國家的宏觀經濟前景

第10章競爭格局

  • 概述
  • 主要參與企業的策略/優勢
  • 2019-2023年收益分析
  • 2023 年市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 品牌/產品比較
  • 主要企業研發費用
  • 公司評價及財務指標
  • 競爭場景

第11章 公司簡介

  • 主要參與企業
    • GEISTLICH PHARMA AG
    • INSTITUT STRAUMANN AG
    • HENRY SCHEIN, INC.
    • ENVISTA
    • ZIMVIE INC.
    • DENTSPLY SIRONA INC.
    • ABBVIE INC.
    • ADVANCED MEDICAL SOLUTIONS GROUP PLC
    • TISSUE REGENIX
    • SEPTODONT HOLDING
    • MEDICAL CONSULT IMPLANTS GMBH
    • MECCELLIS BIOTECH
    • REGEDENT AG
    • REGENITY
    • AD SURGICAL
  • 其他公司
    • LIFENET HEALTH
    • B. & B. DENTAL SRL
    • ALPHA-BIO TEC. LTD.
    • LASAK SRO
    • KEYSTONE DENTAL GROUP
    • NEOSS AG
    • BEGO GMBH & CO. KG
    • BIOTECH DENTAL
    • SAMYANG HOLDINGS CORPORATION
    • RTI SURGICAL

第12章附錄

Product Code: MD 9222

The dental soft-tissue regeneration market is projected to reach USD 0.54 billion by 2029 from USD 0.37 billion in 2024, at a CAGR of 7.8% during the forecast period. The dental soft-tissue regeneration market has had strong growth due to a number of factors such as the rising incidences of periodontal diseases, increasing awareness of oral health, and growing trend of cosmetic dentistry. Moreover, the initiatives to develop healthcare infrastructure in underdeveloped regions demand more dental treatments and related products. Additionally, the advancements in regenerative biomaterials has also played a major role in the market's growth.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million/Billion)
SegmentsBy Product type, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

"By product type, collagen-based segment is expected to have the largest market share in the dental soft-tissue regeneration market."

Based on the product type, the collagen-based membrane segment is expected to dominate the the dental soft-tissue regeneration market due to several factors. Collagen-based membranes acts as barriers to guide tissue growth, where they support the healing of periodontal defects and implant-based defects. Moreover, these membrnes have the ability to integrate with surrounding tissues and supports the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials further support the growth of this market.

"By application, implantology segment is expected to have the largest market share in the dental soft-tissue regeneration market."

Based on application, the implantology segment is expected to hold the largest market share in the dental soft-tissue regeneration market due to the growing aging population, increasing awareness of oral health and increasing demand for cosmetic dentistry. Moreover, to promote healing in peri-implant soft tissues, products like collagen membranes, soft tissue grafts, and advanced bioactive materials are increasingly used. Additionally, innovations in soft tissue regenerative solutions, and increasing awareness of dental aesthetics further support the growth of dental soft-tissue regeneration market.

"By region, North American region is expected to have the largest market share in the dental soft-tissue regeneration market."

North America to register for the highest share of the dental soft-tissue regeneration market during the forecast period due to several factors. The presence of advanced healthcare infrastructure, and high health expenditure rates drive the demand for advanced dental care treatments in this region. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in North America. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting advance dental care treatments. Additonaly, the ongoing research and development in dental technologies and biomaterials, also support this expansion in this region.

A breakdown of the primary participants (supply-side) for the dental soft-tissue regeneration market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
  • By Designation: C-level-45%, Director Level-35%, and Others-20%
  • By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10% .

Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), Dentsply Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), Bego GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).

Research Coverage:

The report analyzes the dental soft-tissue regeneration market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental soft-tissue regeneration market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services, and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries) and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment).
  • Market Penetration: It includes extensive information on products offered by the major players in the global the dental soft-tissue regeneration market. The report includes various segments in product type, application, end user and region.
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user and region.
  • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the dental soft-tissue regeneration market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources for secondary research
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Objectives of primary research
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
    • 2.2.3 TOP-DOWN APPROACH: SUPPLY-SIDE ANALYSIS
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DENTAL SOFT-TISSUE REGENERATION MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE AND COUNTRY (2023)
  • 4.3 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL MIX
  • 4.4 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • 4.5 DENTAL SOFT-TISSUE REGENERATION MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of periodontal diseases
      • 5.2.1.2 Growing demand for cosmetic dentistry
      • 5.2.1.3 Rising popularity of biodegradable biomaterials
      • 5.2.1.4 Advancements in regenerative technologies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Inadequate dental insurance reimbursements and high cost of dental services
      • 5.2.2.2 Dearth of trained dental practitioners
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Introduction of dental service organizations and consolidation of dental practices
      • 5.2.3.2 Growth opportunities in emerging economies
      • 5.2.3.3 Increasing popularity of dental tourism in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Pricing pressure and increased market competition
      • 5.2.4.2 Stringent regulatory environment
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ADVANCEMENTS IN DIGITAL DENTISTRY
    • 5.3.2 INCREASED NUMBER OF MINIMALLY INVASIVE DENTAL PROCEDURES
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 TECHNOLOGY ANALYSIS
    • 5.5.1 KEY TECHNOLOGIES
      • 5.5.1.1 3D bioprinting
    • 5.5.2 COMPLEMENTARY TECHNOLOGIES
      • 5.5.2.1 Laser-assisted technology
    • 5.5.3 ADJACENT TECHNOLOGIES
      • 5.5.3.1 Advanced biomaterials
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.7.2 KEY BUYING CRITERIA
  • 5.8 REGULATORY LANDSCAPE ANALYSIS
    • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2 REGULATORY FRAMEWORK
      • 5.8.2.1 North America
        • 5.8.2.1.1 US
      • 5.8.2.2 Europe
      • 5.8.2.3 Asia Pacific
        • 5.8.2.3.1 India
        • 5.8.2.3.2 China
        • 5.8.2.3.3 Japan
  • 5.9 PATENT ANALYSIS
    • 5.9.1 KEY PATENTS GRANTED
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR HS CODE 300640
    • 5.10.2 EXPORT DATA FOR HS CODE 300640
  • 5.11 PRICING ANALYSIS
    • 5.11.1 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER
    • 5.11.2 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION
  • 5.12 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.13 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.14 ADJACENT MARKET ANALYSIS
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.19 INVESTMENT & FUNDING SCENARIO
  • 5.20 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.21 IMPACT OF AI/GEN AI ON DENTAL SOFT-TISSUE REGENERATION MARKET
  • 5.22 PREVALENCE OF GINGIVAL DISEASES, BY KEY REGION, 2023
  • 5.23 TOTAL NUMBER OF SURGERIES, BY KEY REGION, 2023

6 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE

  • 6.1 INTRODUCTION
    • 6.1.1 COLLAGEN-BASED MEMBRANES
      • 6.1.1.1 Potential to enhance dental tissue regeneration to drive market
    • 6.1.2 AUTOGRAFTS
      • 6.1.2.1 High compatibility and reduced infection risks to drive market
    • 6.1.3 SYNTHETIC BIOMATERIALS
      • 6.1.3.1 Technological advancements in biomaterials to fuel market growth
    • 6.1.4 OTHER PRODUCTS

7 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • 7.1.1 IMPLANTOLOGY
      • 7.1.1.1 Growing need for implant-supported soft-tissue regeneration to drive market
    • 7.1.2 PERIODONTOLOGY
      • 7.1.2.1 Increasing prevalence of periodontal diseases to favor market growth
    • 7.1.3 OTHER APPLICATIONS

8 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 DENTAL HOSPITALS
    • 8.2.1 GROWING AWARENESS OF ORAL HEALTH TO BOOST MARKET
  • 8.3 DSOS & INDEPENDENT CLINICS
    • 8.3.1 ADVANCEMENTS IN DENTAL CARE TO DRIVE DEMAND
  • 8.4 ACADEMIC & RESEARCH INSTITUTES
    • 8.4.1 DEVELOPMENT OF ADVANCED DENTAL SOLUTIONS TO BOOST MARKET GROWTH

9 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American dental soft-tissue regeneration market
    • 9.2.3 CANADA
      • 9.2.3.1 Stringent regulatory compliance to support market growth in Canada
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Germany to dominate dental soft-tissue regeneration market in Europe
    • 9.3.3 UK
      • 9.3.3.1 Rising number of geriatric patients to drive market
    • 9.3.4 FRANCE
      • 9.3.4.1 Well-established healthcare system to drive market
    • 9.3.5 SPAIN
      • 9.3.5.1 Government initiatives for providing dental coverage to support market growth
    • 9.3.6 ITALY
      • 9.3.6.1 Growing penetration of dental products to drive market growth
    • 9.3.7 REST OF EUROPE (ROE)
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Rising geriatric population to support market growth
    • 9.4.3 CHINA
      • 9.4.3.1 Growing geriatric population and increasing per capita income to support market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Growing dental care sector to fuel market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Growing healthcare expenditure to aid market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Well-developed healthcare sector to drive market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Brazil to hold largest share in Latin American market
    • 9.5.3 MEXICO
      • 9.5.3.1 Increasing healthcare infrastructure to propel market growth
    • 9.5.4 ARGENTINA
      • 9.5.4.1 Advancements in dental technology to spur growth
    • 9.5.5 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    • 9.7.1 RISING DISPOSABLE INCOMES TO DRIVE MARKET GROWTH
    • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET
  • 10.3 REVENUE ANALYSIS, 2019-2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Product footprint
      • 10.5.5.3 Application footprint
      • 10.5.5.4 End-user footprint
      • 10.5.5.5 Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 R&D EXPENDITURE OF KEY PLAYERS
  • 10.9 COMPANY VALUATION & FINANCIAL METRICS
  • 10.10 COMPETITIVE SCENARIO
    • 10.10.1 PRODUCT LAUNCHES
    • 10.10.2 DEALS
    • 10.10.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 GEISTLICH PHARMA AG
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Deals
        • 11.1.1.3.2 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 INSTITUT STRAUMANN AG
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 MnM view
        • 11.1.2.3.1 Right to win
        • 11.1.2.3.2 Strategic choices
        • 11.1.2.3.3 Weaknesses & competitive threats
    • 11.1.3 HENRY SCHEIN, INC.
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 ENVISTA
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Deals
    • 11.1.5 ZIMVIE INC.
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 DENTSPLY SIRONA INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches
        • 11.1.6.3.2 Deals
      • 11.1.6.4 MnM view
        • 11.1.6.4.1 Right to win
        • 11.1.6.4.2 Strategic choices
        • 11.1.6.4.3 Weaknesses & competitive threats
    • 11.1.7 ABBVIE INC.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Expansions
    • 11.1.8 ADVANCED MEDICAL SOLUTIONS GROUP PLC
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Deals
    • 11.1.9 TISSUE REGENIX
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
    • 11.1.10 SEPTODONT HOLDING
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Deals
    • 11.1.11 MEDICAL CONSULT IMPLANTS GMBH
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
    • 11.1.12 MECCELLIS BIOTECH
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
    • 11.1.13 REGEDENT AG
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
    • 11.1.14 REGENITY
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Deals
    • 11.1.15 AD SURGICAL
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 LIFENET HEALTH
    • 11.2.2 B. & B. DENTAL S.R.L.
    • 11.2.3 ALPHA-BIO TEC. LTD.
    • 11.2.4 LASAK S.R.O.
    • 11.2.5 KEYSTONE DENTAL GROUP
    • 11.2.6 NEOSS AG
    • 11.2.7 BEGO GMBH & CO. KG
    • 11.2.8 BIOTECH DENTAL
    • 11.2.9 SAMYANG HOLDINGS CORPORATION
    • 11.2.10 RTI SURGICAL

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES
  • TABLE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RISK ASSESSMENT
  • TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY, 2021 VS. 2022
  • TABLE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 7 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 DENTAL SOFT-TISSUE REGENERATION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
  • TABLE 14 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 15 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 16 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2021-2023 (USD)
  • TABLE 17 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2021-2023 (USD)
  • TABLE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025
  • TABLE 19 DENTAL SOFT-TISSUE REGENERATION MARKET: UNMET NEEDS
  • TABLE 20 DENTAL SOFT-TISSUE REGENERATION MARKET: ROLE IN ECOSYSTEM
  • TABLE 21 CASE STUDY 1: GUIDED TISSUE REGENERATION BETWEEN NATURAL TOOTH AND IMPLANT WITH OSSIX PLUS
  • TABLE 22 CASE STUDY 2: ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION
  • TABLE 23 CASE STUDY 3: APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS
  • TABLE 24 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 25 DENTAL SOFT-TISSUE REGENERATION MARKET FOR COLLAGEN-BASED MEMBRANES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 DENTAL SOFT-TISSUE REGENERATION MARKET FOR AUTOGRAFTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 DENTAL SOFT-TISSUE REGENERATION MARKET FOR SYNTHETIC BIOMATERIALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 OTHER DENTAL SOFT-TISSUE REGENERATION PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 30 DENTAL SOFT-TISSUE REGENERATION MARKET FOR IMPLANTOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 DENTAL SOFT-TISSUE REGENERATION MARKET FOR PERIODONTOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 34 DENTAL SOFT-TISSUE REGENERATION MARKET FOR DENTAL HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 DENTAL SOFT-TISSUE REGENERATION FOR DSOS & INDEPENDENT CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 DENTAL SOFT-TISSUE REGENERATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 41 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 42 US: KEY MACROINDICATORS
  • TABLE 43 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 44 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 45 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 46 CANADA: KEY MACROINDICATORS
  • TABLE 47 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 48 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 49 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 50 EUROPE DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 52 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 53 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 54 GERMANY: KEY MACROINDICATORS
  • TABLE 55 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 56 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 57 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 58 UK: KEY MACROINDICATORS
  • TABLE 59 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 60 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 61 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 62 FRANCE: KEY MACROINDICATORS
  • TABLE 63 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 64 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 65 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 66 SPAIN: KEY MACROINDICATORS
  • TABLE 67 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 69 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 70 ITALY: KEY MACROINDICATORS
  • TABLE 71 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 72 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 73 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 74 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 76 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 77 ASIA PACIFIC DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 81 JAPAN: KEY MACROINDICATORS
  • TABLE 82 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 84 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 85 CHINA: KEY MACROINDICATORS
  • TABLE 86 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 88 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 89 INDIA: KEY MACROINDICATORS
  • TABLE 90 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 92 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 93 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 94 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 96 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 97 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 98 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 100 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 101 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 103 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 104 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 107 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 108 BRAZIL: KEY MACROINDICATORS
  • TABLE 109 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 111 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 112 MEXICO: KEY MACROINDICATORS
  • TABLE 113 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 115 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 116 ARGENTINA: KEY MACROINDICATORS
  • TABLE 117 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 119 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 120 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 122 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 123 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 125 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 126 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 128 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 129 DENTAL SOFT-TISSUE REGENERATION MARKET: DEGREE OF COMPETITION
  • TABLE 130 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT FOOTPRINT
  • TABLE 131 DENTAL SOFT-TISSUE REGENERATION MARKET: APPLICATION FOOTPRINT
  • TABLE 132 DENTAL SOFT-TISSUE REGENERATION MARKET: END-USER FOOTPRINT
  • TABLE 133 DENTAL SOFT-TISSUE REGENERATION MARKET: REGION FOOTPRINT
  • TABLE 134 DENTAL SOFT-TISSUE REGENERATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 135 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT TYPE
  • TABLE 136 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
  • TABLE 137 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
  • TABLE 138 DENTAL SOFT-TISSUE REGENERATION MARKET: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 139 DENTAL SOFT-TISSUE REGENERATION MARKET: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 140 GEISTLICH PHARMA AG: COMPANY OVERVIEW
  • TABLE 141 GEISTLICH PHARMA AG: PRODUCTS OFFERED
  • TABLE 142 GEISTLICH PHARMA AG: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 143 GEISTLICH PHARMA AG: EXPANSIONS, JANUARY 2021-OCTOBER 2024
  • TABLE 144 INSTITUT STRAUMANN AG: COMPANY OVERVIEW
  • TABLE 145 INSTITUT STRAUMANN AG: PRODUCTS OFFERED
  • TABLE 146 HENRY SCHEIN, INC.: COMPANY OVERVIEW
  • TABLE 147 HENRY SCHEIN, INC.: PRODUCTS OFFERED
  • TABLE 148 HENRY SCHEIN, INC.: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 149 ENVISTA: COMPANY OVERVIEW
  • TABLE 150 ENVISTA: PRODUCTS OFFERED
  • TABLE 151 ENVISTA: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 152 ZIMVIE INC.: COMPANY OVERVIEW
  • TABLE 153 ZIMVIE INC.: PRODUCTS OFFERED
  • TABLE 154 ZIMVIE INC.: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 155 DENTSPLY SIRONA INC.: COMPANY OVERVIEW
  • TABLE 156 DENTSPLY SIRONA INC.: PRODUCTS OFFERED
  • TABLE 157 DENTSPLY SIRONA INC.: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
  • TABLE 158 DENTSPLY SIRONA INC.: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 159 ABBVIE INC.: COMPANY OVERVIEW
  • TABLE 160 ABBVIE INC.: PRODUCTS OFFERED
  • TABLE 161 ABBVIE INC.: EXPANSIONS, JANUARY 2021-OCTOBER 2024
  • TABLE 162 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW
  • TABLE 163 ADVANCED MEDICAL SOLUTIONS GROUP PLC: PRODUCTS OFFERED
  • TABLE 164 ADVANCED MEDICAL SOLUTIONS GROUP PLC: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 165 TISSUE REGENIX: COMPANY OVERVIEW
  • TABLE 166 TISSUE REGENIX: PRODUCTS OFFERED
  • TABLE 167 SEPTODONT HOLDING: COMPANY OVERVIEW
  • TABLE 168 SEPTODONT HOLDING: PRODUCTS OFFERED
  • TABLE 169 SEPTODONT HOLDING: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 170 MEDICAL CONSULT IMPLANTS GMBH: COMPANY OVERVIEW
  • TABLE 171 MEDICAL CONSULT IMPLANTS GMBH: PRODUCTS OFFERED
  • TABLE 172 MECCELLIS BIOTECH: COMPANY OVERVIEW
  • TABLE 173 MECCELLIS BIOTECH: PRODUCTS OFFERED
  • TABLE 174 REGEDENT AG: COMPANY OVERVIEW
  • TABLE 175 REGEDENT AG: PRODUCTS OFFERED
  • TABLE 176 REGENITY: COMPANY OVERVIEW
  • TABLE 177 REGENITY: PRODUCTS OFFERED
  • TABLE 178 REGENITY: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 179 AD SURGICAL: COMPANY OVERVIEW
  • TABLE 180 AD SURGICAL: PRODUCTS OFFERED
  • TABLE 181 LIFENET HEALTH: COMPANY OVERVIEW
  • TABLE 182 B. & B. DENTAL S.R.L.: COMPANY OVERVIEW
  • TABLE 183 ALPHA-BIO TEC. LTD.: COMPANY OVERVIEW
  • TABLE 184 LASAK S.R.O.: COMPANY OVERVIEW
  • TABLE 185 KEYSTONE DENTAL GROUP: COMPANY OVERVIEW
  • TABLE 186 NEOSS AG: COMPANY OVERVIEW
  • TABLE 187 BEGO GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 188 BIOTECH DENTAL: COMPANY OVERVIEW
  • TABLE 189 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 190 RTI SURGICAL: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: SEGMENTS CONSIDERED
  • FIGURE 2 DENTAL SOFT-TISSUE REGENERATION MARKET: YEARS CONSIDERED
  • FIGURE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RESEARCH DESIGN
  • FIGURE 4 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY INDUSTRY INSIGHTS
  • FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 11 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION: INSTITUT STRAUMANN AG (2023)
  • FIGURE 13 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL SOFT-TISSUE REGENERATION MARKET (2023)
  • FIGURE 14 DENTAL SOFT-TISSUE REGENERATION MARKET: TOP-DOWN APPROACH
  • FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029)
  • FIGURE 16 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 17 DENTAL SOFT-TISSUE REGENERATION MARKET: DATA TRIANGULATION
  • FIGURE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: STUDY ASSUMPTIONS
  • FIGURE 19 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 22 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL SNAPSHOT
  • FIGURE 23 RISING PREVALENCE OF PERIODONTAL DISEASES AND GROWING FOCUS ON DENTAL TOURISM IN EMERGING ECONOMIES TO DRIVE MARKET
  • FIGURE 24 REST OF ASIA PACIFIC AND COLLAGEN-BASED MEMBRANES COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 25 NORTH AMERICA TO DOMINATE MARKET FROM 2024 TO 2029
  • FIGURE 26 CHINA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 28 DENTAL SOFT-TISSUE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 DENTAL SOFT-TISSUE REGENERATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 33 NUMBER OF PATENT PUBLISHED, JANUARY 2014-NOVEMBER 2024
  • FIGURE 34 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL SOFT-TISSUE REGENERATION (JANUARY 2014- NOVEMBER 2024)
  • FIGURE 35 TOP PATENT APPLICANTS, BY JURISDICTION, JANUARY 2014-NOVEMBER 2024
  • FIGURE 36 DENTAL SOFT-TISSUE REGENERATION MARKET: ADJACENT MARKETS
  • FIGURE 37 DENTAL SOFT-TISSUE REGENERATION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 38 DENTAL SOFT-TISSUE REGENERATION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 39 DENTAL SOFT-TISSUE REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 40 DENTAL SOFT-TISSUE REGENERATION MARKET: FUNDING AND NUMBER OF DEALS, 2020-2023
  • FIGURE 41 DENTAL SOFT-TISSUE REGENERATION MARKET: IMPACT OF AI/GEN AI
  • FIGURE 42 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 43 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT
  • FIGURE 44 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT
  • FIGURE 45 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT
  • FIGURE 46 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • FIGURE 47 DENTAL SOFT-TISSUE REGENERATION MARKET: REVENUE ANALYSIS, 2019-2023
  • FIGURE 48 DENTAL SOFT-TISSUE REGENERATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
  • FIGURE 49 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 50 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY FOOTPRINT
  • FIGURE 51 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 52 DENTAL SOFT-TISSUE REGENERATION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023
  • FIGURE 54 EV/EBITDA OF KEY VENDORS
  • FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 56 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT (2023)
  • FIGURE 57 HENRY SCHEIN, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 ENVISTA: COMPANY SNAPSHOT (2023)
  • FIGURE 59 ZIMVIE INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 61 ABBVIE INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 63 TISSUE REGENIX: COMPANY SNAPSHOT (2023)